Llwytho...
Drug Industry Groups Oppose FDA “Quality Metrics” Plan: The Agency Wants to Use Manufacturing Data to Attack Drug Shortages
Raising their voices in nearly unanimous opposition, pharmaceutical manufacturers and their suppliers have mounted a campaign to dissuade the FDA from launching a voluntary program in 2018 that is aimed at reducing drug shortages.
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | P T |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MediMedia USA, Inc.
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5481295/ https://ncbi.nlm.nih.gov/pubmed/28674472 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|